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Lung cancer has been one of the most fundamental leading
causes of death within the past 10 years [1]. The severity of
the disease is related to the metastatic potential and aber-
rant apoptosis of lung cancer cells. Metastasis is the process
when cancer cells transport from their original tumor site and
establish a secondary tumor elsewhere. These aggressive be-
haviors comprise their anoikis resistance and their migrate
abilities [2]. The process of a programmed cell death in an at-
tached condition is called apoptosis whereas anoikis is a cellular
mortality in a detached condition. One of the most essential
processes of metastasis is cell migration where cancer cells are
able to migrate through their surrounding extra cellular matrix
and penetrate into the blood circulating system allowing them
to freely settle at a novel site.Therefore, the discoveries of new
therapeutic strategies targeting metastasis process and apop-
tosis cell death have garnered the most interest in cancer
pharmaceutical sciences. Gigantol, a bibenzyl compound ex-
tracted from Dendrobium draconis, has been a promising natural
derived compound for cancer therapy due to several cyto-
toxic effects in cancer cells [3]. This study has discovered that
Gigantol exhibits a metastasis inhibiting effect through en-
hancing detachment-induced apoptosis and reducingmigration
activities as well as inducing apoptosis in lung cancer cells.
This finding has proven that Gigantol could be a potential
cancer therapeutic compound that should be further devel-
oped for cancer therapy.
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Fig. 1 Effects of Gigantol on lung cancer metastasis.
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